|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019.PubMed/NCBI
|
|
2
|
Sumino J, Uzawa N, Okada N, Miyaguchi K,
Mogushi K, Takahashi K, Sato H, Michikawa C, Nakata Y, Tanaka H and
Amagasa T: Gene expression changes in initiation and progression of
oral squamous cell carcinomas revealed by laser microdissection and
oligonucleotide microarray analysis. Int J Cancer. 132:540–548.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moriya Y, Uzawa N, Morita T, Mogushi K,
Miyaguchi K, Takahashi K, Michikawa C, Sumino J, Tanaka H and
Harada K: The high-temperature requirement factor A3 (HtrA3) is
associated with acquisition of the invasive phenotype in oral
squamous cell carcinoma cells. Oral Oncol. 51:84–89. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yonashiro R, Eguchi K, Wake M, Takeda N
and Nakayama K: Pyruvate dehydrogenase PDH-E1β controls tumor
progression by altering the metabolic status of cancer cells.
Cancer Res. 78:1592–1603. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the warburg effect: The metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
DE Lima PO, Jorge CC, Oliveira DT and
Pereira MC: Hypoxic condition and prognosis in oral squamous cell
carcinoma. Anticancer Res. 34:605–612. 2014.PubMed/NCBI
|
|
8
|
Pavlova NN and Thompson CB: The emerging
hallmarks of cancer metabolism. Cell Metabo. 23:27–47. 2016.
View Article : Google Scholar
|
|
9
|
Müller S: Update from the 4th edition of
the World Health Organization of head and neck tumours: Tumours of
the oral cavity and mobile tongue. Head Neck Pathol. 11:33–40.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Angadi VC and Angadi PV: GLUT-1
immunoexpression in oral epithelial dysplasia, oral squamous cell
carcinoma, and verrucous carcinoma. J Oral Sci. 57:115–122. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ribeiro M, Teixeira SR, Azevedo MN, Fraga
AC Jr, Gontijo AP and Vêncio EF: Expression of hypoxia-induced
factor-1 alpha in early-stage and in metastatic oral squamous cell
carcinoma. Tumour Biol. 39:10104283176955272017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
DeBerardinis RJ and Chandel NS:
Fundamentals of cancer metabolism. Sci Adv. 2:e16002002016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mueckler M and Thorens B: The SLC2 (GLUT)
family of membrane transporters. Mol Aspects Med. 34:121–138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Macheda ML, Rogers S and Best JD:
Molecular and cellular regulation of glucose transporter (GLUT)
proteins in cancer. J Cell Physiol. 202:654–662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barron CC, Bilan PJ, Tsakiridis T and
Tsiani E: Facilitative glucose transporters: Implications for
cancer detection, prognosis and treatment. Metabolism. 65:124–139.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mendez LE, Manci N, Cantuaria G,
Gomez-Marin O, Penalver M, Braunschweiger P and Nadji M: Expression
of glucose transporter-1 in cervical cancer and its precursors.
Gynecol Oncol. 86:138–143. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rudlowski C, Becker AJ, Schroder W, Rath
W, Büttner R and Moser M: GLUT1 messenger RNA and protein induction
relates to the malignant transformation of cervical cancer. Am J
Clin Pathol. 120:691–698. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hamanaka RB and Chandel NS: Targeting
glucose metabolism for cancer therapy. J Exp Med. 209:211–215.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ancey PB, Contat C and Meylan E: Glucose
transporters in cancer-from tumor cells to the tumor
microenvironment. FEBS J. 2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mandujano-Tinoco EA, Gallardo-Pérez JC,
Marín-Hernández A, Moreno-Sánchez R and Rodríguez-Enríquez S: Anti-
mitochondrial therapy in human breast cancer multi-cellular
spheroids. Biochim Biophys Acta. 1833:541–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grimm M, Cetindis M, Lehmann M, Biegner T,
Munz A, Teriete P, Kraut W and Reinert S: Association of cancer
metabolism-related proteins with oral carcinogenesis-indications
for chemoprevention and metabolic sensitizing of oral squamous cell
carcinoma? J Transl Med. 12:2082014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grimm M, Munz A, Teriete P, Nadtotschi T
and Reinert S: GLUT-1(+)/TKTL1(+) coexpression predicts poor
outcome in oral squamous cell carcinoma. Oral Surg Oral Med Oral
Pathol Oral Radiol. 117:743–753. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gottfried E, Kunz-Schughart LA, Ebner S,
Mueller-Klieser W, Hoves S, Andreesen R, Mackensen A and Kreutz M:
Tumor-derived lactic acid modulates dendritic cell activation and
antigen expression. Blood. 107:2013–2021. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fischer K, Hoffmann P, Voelkl S,
Meidenbauer N, Ammer J, Edinger M, Gottfried E, Schwarz S, Rothe G,
Hoves S, et al: Inhibitory effect of tumor cell-derived lactic acid
on human T cells. Blood. 109:3812–3819. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goetze K, Walenta S, Ksiazkiewicz M,
Kunz-Schughart LA and Mueller-Klieser W: Lactate enhances motility
of tumor cells and inhibits monocyte migration and cytokine
release. Int J Oncol. 39:453–463. 2011.PubMed/NCBI
|
|
26
|
Carmona-Fontaine C, Bucci V, Akkari L,
Deforet M, Joyce JA and Xavier JB: Emergence of spatial structure
in the tumor microenvironment due to the warburg effect. Proc Natl
Acad Sci USA. 110:19402–19407. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Colegio OR, Chu NQ, Szabo AL, Chu T,
Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC,
Phillips GM, et al: Functional polarization of tumour-associated
macrophages by tumour-derived lactic acid. Nature. 513:559–563.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Constant JS, Feng JJ, Zabel DD, Yuan H,
Suh DY, Scheuenstuhl H, Hunt TK and Hussain MZ: Lactate elicits
vascular endothelial growth factor from macrophages: A possible
alternative to hypoxia. Wound Repair Regen. 8:353–360. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schmid SA, Gaumann A, Wondrak M, Eckermann
C, Schulte S, Mueller-Klieser W, Wheatley DN and Kunz-Schughart LA:
Lactate adversely affects the in vitro formation of endothelial
cell tubular structures through the action of TGF-beta1. Exp Cell
Res. 313:2531–2549. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Végran F, Boidot R, Michiels C, Sonveaux P
and Feron O: Lactate influx through the endothelial cell
monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway
that drives tumor angiogenesis. Cancer Res. 71:2550–2560. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sonveaux P, Copetti T, De Saedeleer CJ,
Végran F, Verrax J, Kennedy KM, Moon EJ, Dhup S, Danhier P, Frérart
F, et al: Targeting the lactate transporter MCT1 in endothelial
cells inhibits lactate-induced HIF-1 activation and tumor
angiogenesis. PLoS One. 7:e334182012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stern R, Shuster S, Neudecker BA and
Formby B: Lactate stimulates fibroblast expression of hyaluronan
and CD44: The Warburg effect revisited. Exp Cell Res. 276:24–31.
2002. View Article : Google Scholar : PubMed/NCBI
|
